SCM
ITCI

Suffolk Capital Management’s Intra-Cellular Therapies Inc. ITCI Stock Holding History

Suffolk Capital Management’s Portfolio ITCI Stock Details ITCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-46,564
Closed -$703K – 151
2016
Q4 		$703K Buy
46,564
+2,709
+6% +$38.3K 0.1% 126
2016
Q3 		$668K Sell
43,855
-16,899
-28% -$683K 0.09% 128
2016
Q2 		$2.36M Sell
60,754
-278
-0.5% -$9.99K 0.3% 101
2016
Q1 		$1.7M Buy
61,032
+30,527
+100% +$1.02M 0.23% 122
2015
Q4 		$1.64M Buy
+30,505
New +$1.54M 0.21% 126

Other funds holding ITCI

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BB
BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
HIM
Hillhouse Investment Management Grand Cayman, Cayman Islands $3.13B AUM 7.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.04B AUM 49.7% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return
RPAM
Rhenman & Partners Asset Management Stockholm, Sweden $810M AUM 30.2% 1-Year Est. Return